AstraZeneca Plc plans to invest $50 billion in the US before 2030, becoming the latest European pharma company to ratchet up spending in the country ahead of potential tariffs on imported medicines.
www.bloomberg.com
#AstraZenecaVows #Spend #Billion #Manufacturing #Development
AstraZeneca Vows to Spend $50 Billion on US Manufacturing, Development
